National Health (IVF/Gift Program) Special Arrangement Amendment Instrument 2012 (No. 2) (No. PB 78 of 2012) (Cth)
PB 78 of 2012
National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2012 (No.2)
National Health Act 1953
I, KIM BESSELL, First Assistant Secretary A/g, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 25 September 2012
KIM BESSELL
First Assistant Secretary A/g
Pharmaceutical Benefits Divison
Department of Health and Ageing
1 Name of Instrument
(1) This Instrument is the National Health (IVF/GIFT Program)
Special Arrangement Amendment Instrument 2012 (No.2).
(2) This Instrument may also be cited as PB 78 of 2012.
2 Commencement
This Instrument commences on 1 October 2012.
3 Amendment of PB 93 of 2011
(1) Schedule 1 of the National Health (IVF/GIFT Program) Special Arrangement 2011 (PB 93 of 2011) is omitted and replaced by Schedule 1 of this Instrument.
(2) Schedule 2 makes other amendments to PB 93 of 2011.
Schedule 1 Pharmaceutical benefits covered by this Special Arrangement and related information
(sections 5,6 and 7)
| Listed Drug | Form | Manner of Administration | Brand | Responsible Person | Section 100 only |
| Cetrorelix | Powder for injection 250 micrograms (as acetate) with diluent | Injection | Cetrotide | SG | D(100) |
| Choriogonadotropin Alfa | Solution for injection 250 micrograms in 0.5ml pre-filled pen | Injection | Ovidrel | SG | D(100) |
| Choriogonadotropin Alfa | Solution for injection 250 micrograms in 0.5 mL pre‑filled syringe | Injection | Ovidrel | SG | D(100) |
| Chorionic Gonadotrophin | Injection set containing 3 ampoules powder for injection 1,500 units and 3 ampoules solvent 1 mL | Injection | Pregnyl | MK | |
| Chorionic Gonadotrophin | Powder for injection 5’000 units with solvent | Injection | Pregnyl | MK | PB(100) |
| Corifollitropin Alfa | Solution for injection 100 micrograms in 0.5ml single dose pre‑filled syringes | Injection | Elonva | MK | |
| Corifollitropin Alfa | Solution for injection 150 micrograms in 0.5ml single dose pre‑filled syringes | Injection | Elonva | MK | |
| Follitropin Alfa | Injection 300 I.U. in 0.5 mL multi‑dose cartridge | Injection | Gonal‑f Pen | SG | |
| Follitropin Alfa | Injection 450 I.U. in 0.75 mL multi‑dose cartridge | Injection | Gonal‑f Pen | SG | |
| Follitropin Alfa | Injection 900 I.U. in 1.5 mL multi‑dose cartridge | Injection | Gonal‑f Pen | SG | |
| Follitropin Beta | Solution for injection 300 I.U. in 0.36 mL multi‑dose cartridge | Injection | Puregon 300 IU/0.36 mL | MK | |
| Follitropin Beta | Solution for injection 600 I.U. in 0.72 mL multi‑dose cartridge | Injection | Puregon 600 IU/0.72 mL | MK | |
| Follitropin Beta | Solution for injection 900 I.U. in 1.08 mL multi‑dose cartridge | Injection | Puregon 900 IU/1.08 mL | MK | |
| Ganirelix | Injection 250 micrograms (as acetate) in 0.5mL pre‑filled syringe | Injection | Orgalutran | MK | D(100) |
| Human Menopausal Gonadotrophin | Powder for injection 600IU with solvent | Injection | Menopur 600 | FP | D(100) |
| Human Menopausal Gonadotrophin | Powder for injection 1200IU with solvent | Injection | Menopur 1200 | FP | D(100) |
| Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses | Nasal | Synarel | PF | |
| Progesterone | Vaginal gel (prolonged release) 90 mg in single dose pre‑filled applicator | Vaginal | Crinone 8% | SG | D(100) |
| Progesterone | Pessary 100 mg | Vaginal | Orion Laboratories Pty Ltd | ON | D(100) |
| Progesterone | Pessary 200 mg | Vaginal | Orion Laboratories Pty Ltd | ON | D(100) |
Schedule 2 Amendments
[1] Subsection 7(1)
omit:
letter ‘D’
insert:
code ‘D(100)’
[2] Subsection 7(3)
omit:
letters ‘PB’
insert:
code ‘PB(100)’
[3] Schedule 2, before entry for MK
insert:
FP
Ferring Pharmaceuticals Pty Ltd
87 003 037 170
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the
Legislative Instruments Act 2003. See
0
0
0